iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,745.00
+80.00 (2.18%)
Feb 19, 2026, 3:19 PM KST

iNtRON Biotechnology Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
112,350183,560291,422269,879709,999915,063
Market Cap Growth
-38.90%-37.01%7.98%-61.99%-22.41%97.15%
Enterprise Value
77,422129,604224,880175,332642,575858,619
Last Close Price
3665.005443.048374.557664.0819843.6526253.96
PE Ratio
---47.2572.9961.22
PS Ratio
20.2228.6030.4019.2724.2320.14
PB Ratio
1.522.193.012.547.0110.72
P/TBV Ratio
1.542.233.062.587.0910.88
P/FCF Ratio
---72.0052.88401.50
P/OCF Ratio
--93.4845.1543.10128.32
EV/Sales Ratio
13.9320.1923.4612.5221.9318.90
EV/EBITDA Ratio
---1999.3055.3349.62
EV/EBIT Ratio
----63.7654.56
EV/FCF Ratio
-12.99--46.7847.86376.74
Debt / Equity Ratio
0.040.020.000.300.450.12
Debt / EBITDA Ratio
---356.593.940.59
Debt / FCF Ratio
---8.343.414.51
Net Debt / Equity Ratio
-0.47-0.58-0.59-0.73-0.67-0.65
Net Debt / EBITDA Ratio
6.6615.1141.35-878.94-5.83-3.23
Net Debt / FCF Ratio
5.8638.5112.15-20.56-5.04-24.52
Asset Turnover
0.070.070.080.100.230.48
Inventory Turnover
2.462.574.204.896.0113.19
Quick Ratio
8.6837.9676.133.503.736.16
Current Ratio
10.7039.0377.593.543.776.40
Return on Equity (ROE)
-7.70%-2.87%-9.56%5.50%10.42%19.88%
Return on Assets (ROA)
-5.31%-3.54%-1.71%-0.63%4.96%10.38%
Return on Invested Capital (ROIC)
-19.39%-13.93%-9.51%-3.24%29.38%68.95%
Return on Capital Employed (ROCE)
-9.70%-6.20%-3.40%-1.40%8.40%17.90%
Earnings Yield
-5.60%-1.41%-3.33%2.12%1.37%1.63%
FCF Yield
-5.30%-0.69%-1.60%1.39%1.89%0.25%
Dividend Yield
2.73%1.84%----
Buyback Yield / Dilution
3.69%0.87%2.16%-0.58%4.41%-6.08%
Total Shareholder Return
6.42%2.70%2.16%-0.58%4.41%-6.08%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.